Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-03-10

Clinical Trial Update: Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for EYS606 in non-infectious uveitis across Phase 1 and Phase 2, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EYS606

Snippet

Sponsor: Eyevensys | Conditions: Non-infectious Uveitis | Phase 1, Phase 2 | Status: COMPLETED